Evidence map›Paper›PMID 35236476›Full record

ArticleArthroplasty (London, England)2020

Can urinary CTX-II be a biomarker for knee osteoarthritis?

Piti Arunrukthavon, Danai Heebthamai, Prapasri Benchasiriluck, Supinda Chaluay, Thanainit Chotanaphuti, Saradej Khuangsirikul

Open access · diamondAbstract read
In one paragraph

Article in Arthroplasty (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 29 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Identification of Surrogate Biomarkers for Mucopolysaccharidosis Type IVA.International journal of molecular sciences · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Construction of multi-scale feature fusion segmentation model of MRI knee images based on dual attention mechanism weighted aggregation.Technology and health care : official journal of the European Society for Engineering and Medicine · 2024
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Piti ArunrukthavonDepartment of Orthopedic Surgery, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand.
Danai HeebthamaiDepartment of Orthopedic Surgery, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand.
Prapasri BenchasiriluckCenter of Private Research and Innovation Accelerator, Phyathai 2 Hospital, Bangkok, Thailand.
Supinda ChaluayPhyathai Orthopedic Institute, Phyathai 2 Hospital, Bangkok, Thailand.
Thanainit ChotanaphutiDepartment of Orthopedic Surgery, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand.
Saradej KhuangsirikulDepartment of Orthopedic Surgery, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand. ksaradej@yahoo.com.ORCID http://orcid.org/0000-0003-4256-5432
Phramongkutklao Hospital · THBangkok Hospital · TH

Funding

Phyathai 2 hospital 240,000 baht
6 · The paper itself

Abstract

backgroundEarly diagnosis of knee osteoarthritis (OA) remains a diagnostic challenge. Urinary C-terminal cross-linked telopeptide of type II collagen (urinary CTX-II) is one of the potential OA biomarkers. However, conclusive evidence regarding the use of this biomarker as a tool for early diagnosis is still lacking. The purposes of this study were to compare urinary CTX-II levels in patients with knee OA and in healthy controls, to evaluate the correlation between urinary CTX-II levels, radiographic severity of OA, and patient-reported outcomes and to evaluate the effect of age and gender on urinary CTX-II levels in the Asian populations.

methodsTwo groups were studied. The OA group included 78 patients with knee OA aged > 40 years who met the diagnostic criteria for knee OA described by the American College of Rheumatology (ACR). The control group consisted of 51 healthy participants age > 40 years without clinical or radiographic evidence of knee OA. Bilateral knee radiographs were taken and classified according to the Kellgren and Lawrence (KL) grading system. Urinary CTX-II was measured using a competitive ELISA test and Western Ontario and Mcmaster Universities Arthritis Index (WOMAC) was also recorded in all participants.

resultsUrinary CTX-II was significantly higher in the OA group than in the control group (p < 0.001). The severe knee OA group (KL grade 3 and 4) had higher urinary CTX-II levels than mild knee OA group (KL grade 2) but the difference did not reach statistical significance (p = 0.2). There was a moderate correlation between urinary CTX-II levels and KL grades (r = 0.405, p < 0.001) and a weak correlation between urinary CTX-II levels and WOMAC index scores (r = 0.367, p < 0.001). Multiple regression analysis showed that urinary CTX-II was independently associated with KL grades. Whereas age, gender, and WOMAC index had no statistically significant influence on the urinary CTX-II levels.

conclusionsPatients with knee OA had higher urinary CTX-II levels than healthy controls. Moreover, levels of urinary CTX-II were independently correlated with radiographic severity of knee OA. Age, gender, and patient-reported outcomes exerted no effect on the urinary CTX-II levels. LEVEL OF EVIDENCE: Diagnostic Level III.

Indexed as

BiomarkerKnee osteoarthritisUrinary CTX-II

Identifiers

PMID35236476
PMCPMC8796402
OpenAlexW3029015220

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.